Source: Business Wire

Press Release: Melior Discovery : Melior Is Selected as a Top 20 CRO by Pharma Tech Outlook

EXTON, Pa.--(BUSINESS WIRE)-- #CRO--Melior Discovery, Inc. (Melior) announced today that it has been selected as a top-20 CRO in the most recent edition of Pharma Tech Outlook magazine. This cover story article recognized Melior's approach towards providing bespoke solutions in the preclinical in vivo pharmacology space and its pioneering achievements in phenotypic screening vis-à-vis its theraTRACE® platform. "I am very proud of the acknowledgment provided by the Pharma Tech editors on the strides th

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew G. Reaume's photo - President & CEO of Melior Discovery

President & CEO

Andrew G. Reaume

CEO Approval Rating

70/100

Read more